A quick review of the publicly-traded stem cell stocks I’ve been following in 2021 finds mostly discouraging news, but a few firms relatively outperformed the other publically-traded biotechs. One had some great news today. In this post, I’m doing a brief overview of how things went this year in the regenerative medicine space. I’m going […]
2021 scorecard for stem cell stocks: REGN, VCEL, CCEL, LCTX did best Read More »
A type of human cells used in research called HEK cells or 293s has been much in the news lately. This is mainly related to COVID-19 vaccine research. There seem to be many misunderstandings about 293 cells. For that reason, I thought I’d do this post to clear things up. I’ve been working with these
Explainer on 293 or HEK cells and their use in COVID vaccine research Read More »
Joe Rogan first popped up more squarely on my radar screen years ago because of a concerning video that’s out there of him talking with Mel Gibson about stem cells. At the time it was one of the most-watched videos on YouTube on stem cells. I took apart that stem cell video and its claims including
About that Joe Rogan stem cell treatment & clinic promotion Read More »
I’ve been concerned that the journal Stem Cells Translational Medicine has been publishing some iffy papers from unproven stem cell clinics recently including from a Panama stem cell clinic called the Stem Cell Institute. Back in 2019, I took the unusual step of raising the question of whether a Stem Cells Translational Medicine paper from Neil Riordan,
Questions remain after Stem Cells Translational Medicine retracts clinic pub Read More »
There are so many stem cell clinics out there that it can be hard to keep track of them and the news about them, but a big court victory against a Manhattan stem cell clinic by New York State Attorney General Letitia James is notable for several reasons. Injunction on Park Avenue Stem Cell clinic
New York wins $5.1 million in suit against Manhattan stem cell clinic Read More »
One of the most interesting parts of running The Niche is that I get all these questions about stem cells and related matters from readers. I try to answer questions regularly by email, but sometimes the volume catches up with me. For that reason I periodically try to do posts answering such questions, which has
Answering reader questions: snorting stem cells, Regenexx, exosomes Read More »
What are your favorite cells? The stem variety? T-cells? I have a hard time choosing just one favorite. The first news item I feature talks new imaging methods to see deep inside any cells. Have a favorite organelle? The secret lives of cells — as never seen before, Nature. This news item covers newer imaging techniques
Recommended reads: secrets of cells, T-cells, CRISPR Read More »
Leigh Turner’s new Cell Stem Cell paper on the unproven stem cell clinic industry following up on our collaborative work together in 2015-2016 is great work but very discouraging. He found more than 2,700 clinics run by more than 1,000 firms in the U.S. This is several-fold growth since 2016. I’m very glad that Leigh has continued this line of
Turner pub charts runaway stem cell clinic industry; FDA needs to think big now Read More »
The other day I was talking with some folks about stem cell policy on Zoom, which was great, but one phrase from them jumped out at me and gave me a laugh. “Joe Rogan is the Gwyneth Paltrow for bros.” It also just rings true to me. Some readers of The Niche may remember that
Weekly reads: Joe Rogan, stem cell, diet, clinics, more Read More »
Clade Therapeutics has been pursuing the idea of using gene-editing to make universally compatible cells. The potential here is big. What if you could make cloaked stem cells that could be used to produce cellular therapies that could be given to most patients without fear of immune rejection? Clade Therapeutics Boston Business Journal covers the
Clade Therapeutics pursues universal cells for cancer therapy Read More »